• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

南部非洲恶性疟原虫分离株对卤泛群的体外敏感性

In vitro sensitivity of southern African isolates of Plasmodium falciparum to halofantrine.

作者信息

Freese J A, Rossouw E J, Gouws E, Sharp B L, Markus M B

机构信息

Medical Research Council, Congella, South Africa.

出版信息

Ann Trop Med Parasitol. 1993 Jun;87(3):235-9. doi: 10.1080/00034983.1993.11812761.

DOI:10.1080/00034983.1993.11812761
PMID:8257233
Abstract

Twenty southern African isolates of Plasmodium falciparum and a 'control' Gambian strain were tested in vitro for their sensitivity to halofantrine. The concentration required to inhibit 50% of parasite growth, the IC50, ranged from 0.039 to 15.000 nmol/litre, with a mean of 4.619 nmol/litre. These IC50 values were comparable with those obtained in studies carried out in West Africa but were higher than the IC50 of South-East Asian isolates. All 21 isolates examined in the present study had minimum inhibitory concentrations (MIC) of 32 nmol/litre or less, with a median MIC value of 8 nmol/litre. Halofantrine was equally active against chloroquine-sensitive and chloroquine-resistant isolates and was also active against pyrimethamine-resistant strains. Indications are that this drug would be suitable for the treatment of P. falciparum malaria in the southern African region.

摘要

对20株来自非洲南部的恶性疟原虫分离株和1株“对照”冈比亚菌株进行了体外氯氟菲醇敏感性测试。抑制50%寄生虫生长所需的浓度,即半数抑制浓度(IC50),范围为0.039至15.000纳摩尔/升,平均为4.619纳摩尔/升。这些IC50值与在西非进行的研究中获得的值相当,但高于东南亚分离株的IC50。本研究中检测的所有21株分离株的最低抑菌浓度(MIC)均为32纳摩尔/升或更低,MIC中值为8纳摩尔/升。氯氟菲醇对氯喹敏感和氯喹耐药的分离株同样有效,对乙胺嘧啶耐药菌株也有效。有迹象表明,这种药物适用于非洲南部地区恶性疟原虫疟疾的治疗。

相似文献

1
In vitro sensitivity of southern African isolates of Plasmodium falciparum to halofantrine.南部非洲恶性疟原虫分离株对卤泛群的体外敏感性
Ann Trop Med Parasitol. 1993 Jun;87(3):235-9. doi: 10.1080/00034983.1993.11812761.
2
In vitro susceptibility of Plasmodium falciparum isolates to halofantrine in the Central Province of Papua New Guinea.巴布亚新几内亚中部省份恶性疟原虫分离株对卤泛群的体外敏感性
P N G Med J. 1998 Mar;41(1):30-6.
3
In vitro activity of halofantrine and its relationship to other standard antimalarial drugs against African isolates and clones of Plasmodium falciparum.卤泛群对恶性疟原虫非洲分离株和克隆株的体外活性及其与其他标准抗疟药物的关系。
Am J Trop Med Hyg. 1992 Oct;47(4):521-7. doi: 10.4269/ajtmh.1992.47.521.
4
In vitro sensitivity of Plasmodium falciparum to halofantrine compared with chloroquine, quinine and mefloquine in the region of Bobo-Dioulasso, Burkina Faso (West Africa).在布基纳法索(西非)博博迪乌拉索地区,恶性疟原虫对卤泛群与氯喹、奎宁和甲氟喹的体外敏感性比较
Trop Med Int Health. 1998 May;3(5):381-4.
5
In-vitro sensitivity of Plasmodium falciparum to chloroquine, halofantrine, mefloquine and quinine in Madagascar.马达加斯加恶性疟原虫对氯喹、卤泛群、甲氟喹和奎宁的体外敏感性
East Afr Med J. 2002 May;79(5):237-41.
6
In vitro activity of antimalarials against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon.抗疟药对喀麦隆雅温得恶性疟原虫临床分离株的体外活性。
Am J Trop Med Hyg. 1996 Sep;55(3):254-8. doi: 10.4269/ajtmh.1996.55.254.
7
In vitro response of Plasmodium falciparum to atovaquone and correlation with other antimalarials: comparison between African and Asian strains.
Am J Trop Med Hyg. 1997 Mar;56(3):315-7. doi: 10.4269/ajtmh.1997.56.315.
8
Type RI resistance to halofantrine in West Africa.西非卤泛群的RI型抗性。
Trop Med Parasitol. 1991 Dec;42(4):413-4.
9
In vitro susceptibility of African isolates of Plasmodium falciparum from Gabon to pyronaridine.加蓬恶性疟原虫非洲分离株对咯萘啶的体外敏感性
Am J Trop Med Hyg. 1999 Jan;60(1):105-8. doi: 10.4269/ajtmh.1999.60.105.
10
In vitro activity of artemether against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial drugs.与标准抗疟药物相比,蒿甲醚对恶性疟原虫非洲分离株(塞内加尔)的体外活性。
Am J Trop Med Hyg. 1998 Mar;58(3):354-7. doi: 10.4269/ajtmh.1998.58.354.